These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 33117717)
1. Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis. Wan Z; Han B Front Oncol; 2020; 10():579221. PubMed ID: 33117717 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations. Liu YC; Illar GM; Bailey NG J Clin Pathol; 2020 Nov; 73(11):728-736. PubMed ID: 32217616 [TBL] [Abstract][Full Text] [Related]
3. Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study. Fei F; Jariwala A; Pullarkat S; Loo E; Liu Y; Tizro P; Ali H; Otoukesh S; Amanam I; Artz A; Ally F; Telatar M; Nakamura R; Marcucci G; Afkhami M Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337700 [TBL] [Abstract][Full Text] [Related]
4. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343 [TBL] [Abstract][Full Text] [Related]
5. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management. Patnaik MM; Tefferi A Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682 [TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of MDS/MPN overlap syndromes. Hunter AM; Padron E Best Pract Res Clin Haematol; 2020 Sep; 33(3):101195. PubMed ID: 33038984 [TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management". Patnaik MM; Tefferi A Am J Hematol; 2021 Mar; 96(3):379-394. PubMed ID: 33428785 [TBL] [Abstract][Full Text] [Related]
10. Many faces of SF3B1-mutated myeloid neoplasms: concurrent mutational profiles contribute to the diverse clinical and morphologic features. Aqil B; Sukhanova M; Behdad A; Jennings L; Lu X; Chen Q; Chen YH; Gao J Hum Pathol; 2022 Nov; 129():81-89. PubMed ID: 36087739 [TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review. Fontana D; Elli EM; Pagni F; Piazza R Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370785 [TBL] [Abstract][Full Text] [Related]
12. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management". Patnaik MM; Tefferi A Am J Hematol; 2019 Apr; 94(4):475-488. PubMed ID: 30618061 [TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): More than just a "catch-all" term? Shallis RM; Zeidan AM Best Pract Res Clin Haematol; 2020 Jun; 33(2):101132. PubMed ID: 32460977 [TBL] [Abstract][Full Text] [Related]
14. Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms. Gerke MB; Christodoulou I; Karantanos T Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568631 [TBL] [Abstract][Full Text] [Related]
15. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management. Patnaik MM; Tefferi A Am J Hematol; 2017 Mar; 92(3):297-310. PubMed ID: 28188970 [TBL] [Abstract][Full Text] [Related]
16. The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm. Ibrar W; Zhang W; Cox JL; Cushman-Vokoun A; Fu K; Greiner TC; Yuan J Int J Lab Hematol; 2021 Dec; 43(6):1501-1509. PubMed ID: 34270867 [TBL] [Abstract][Full Text] [Related]
18. Progression in Myeloid Neoplasms: Beyond the Myeloblast. Faria C; Tzankov A Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015 [TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review. Patnaik MM; Lasho T Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):460-464. PubMed ID: 33275673 [TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Ringing in a new future. Nathan DI; Feld J; El Jamal SM; Mascarenhas J; Tremblay D Leuk Res; 2022 Apr; 115():106820. PubMed ID: 35279478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]